Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

August 15, 2017

Study Completion Date

May 30, 2018

Conditions
Acute PancreatitisIntra-abdominal Hypertension
Interventions
DRUG

Neostigmine Methylsulfate 1 MG/ML

The initial dose was 1mg, intramuscular injection(IM) once every 12 hours. If there is no defecation after 12 hours, the dose is increased to 1mg IM once every 8 hours; if there is no defecation after 24 hours, the dose is increased to 1mg IM once every 6 hours. If the abdominal pressure drops below 12mmhg, neostigmine will be stopped, otherwise it will be used continuously for 7 days.

COMBINATION_PRODUCT

Conservative treatment

Intragastric administration of paraffin oil, 50ml,once every 8 hours;gastrointestinal decompression with nasogastric tube and rectal tub; lycerin enema promotes defecation; patients with ascites undergo percutaneous puncture drainage. Other conservative medical treatment recommended by the guidelines.

Trial Locations (1)

330006

Affiliated Hospital of Nanchang University, Nanchang

All Listed Sponsors
lead

The First Affiliated Hospital of Nanchang University

OTHER

NCT02543658 - Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension | Biotech Hunter | Biotech Hunter